Day: January 10, 2026
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026
Phase 1 dose-escalation trial of FHD-909 (LY4050784) advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung cancer (NSCLC)
Selective CBP degrader program with potential in ER+ breast cancer on track to be IND-ready in 2026
Selective EP300 degrader program shows preclinical superior anti-tumor efficacy and tolerability over dual CBP/EP300; tracking to IND-enabling studies in 2026
Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on January 13, 2026, and allows for continued investment...
VR Announces Further Upsize of Brokered Private Placement Led by Centurion One Capital to $2,750,000
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) — VR Resources Limited (“VR” or the “Company”, TSXV: VRR) is pleased to announce a further upsize to its previously announced brokered private placement offering (the “Offering”). Pursuant to the upsize, the Company will now issue up to 17,187,500 units (the “Units) for aggregate gross proceeds of $2,750,000. Centurion One Capital Corp. (the “Lead Agent”) is acting as lead agent and sole bookrunner and maintains an option exercisable, in whole or in part, at the sole discretion of the Lead Agent, to sell up to $500,000 in additional Units pursuant to the Offering.
As previously disclosed, each Unit will be offered at an issue price of $0.16 and will consist of one common...
Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Walmart Inc. (Nasdaq: WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 – the first trading day following the third Friday of the month.
Walmart Inc. will replace AstraZeneca PLC (Nasdaq: AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™ (NDX70™), Nasdaq-100 ex Top 30 UCITS™ (NDX70U™), Nasdaq-100 Sustainable ESG Select™ (NDXSES™), Nasdaq-100...
